HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Kühr Selected Research

Thomas Kühr Research Topics

Disease

3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
03/2013 - 01/2009
1Adenocarcinoma
09/2019
1Stomach Neoplasms (Stomach Cancer)
09/2019
1Normal Pressure Hydrocephalus
07/2016
1Dementia (Dementias)
07/2016
1Sarcoma (Soft Tissue Sarcoma)
08/2014
1Leiomyosarcoma
08/2014
1Primary Myelofibrosis (Myelosclerosis)
04/2013
1Neoplasms (Cancer)
01/2009
1BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative)
10/2004
1Myeloproliferative Disorders (Myeloproliferative Disorder)
10/2004
1Eosinophilia
10/2004
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2004
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2003
1Carcinogenesis
01/2002
1B-Cell Leukemia (Leukemia, B Cell)
01/2002
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2002

Drug/Important Bio-Agent (IBA)

2Imatinib Mesylate (Gleevec)FDA Link
01/2009 - 10/2004
1human ERBB2 proteinIBA
09/2019
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
07/2016
1Sorafenib (BAY 43-9006)FDA Link
08/2014
1Lenalidomide (CC 5013)FDA Link
04/2013
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
10/2004
1Proteins (Proteins, Gene)FDA Link
10/2004
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2004
1Codon (Codons)IBA
10/2003
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2002
1EnzymesIBA
01/2002

Therapy/Procedure

3Therapeutics
09/2019 - 01/2009
2Aftercare (After-Treatment)
03/2013 - 01/2009
1Time-to-Treatment
08/2014